Beta-blockers in thyrotoxicosis.
D013956:Antithyroid Agents; D001262:Atenolol / Q000627:therapeutic use*; D006801:Humans; D006980:Hyperthyroidism / Q000188:drug therapy*; D008657:Metabolic Clearance Rate / Q000187:drug effects; D011217:Practolol / Q000627:therapeutic use*; D011412:Propanolamines / Q000627:therapeutic use*; D011433:Propranolol / Q000627:therapeutic use*; D013974:Thyroxine / Q000378:metabolism; D014284:Triiodothyronine / Q000037:antagonists & inhibitors; D014285:Triiodothyronine, Reverse / Q000378:metabolism
D013956:Antithyroid Agents; D011412:Propanolamines; D014284:Triiodothyronine; D001262:Atenolol; D014285:Triiodothyronine, Reverse; D011433:Propranolol; D013974:Thyroxine; D011217:Practolol